Search results for "Venous thromboembolism"


 
Results 1 - 10 of about 97 for "Venous thromboembolism".
Sort by: Relevance | Newest | Oldest

Patients with provoked VTE often on anticoagulation longer than recommended

Three variables were associated with receiving anticoagulation for longer than three months after a provoked venous thromboembolism (VTE): direct oral anticoagulant use, history of VTE, and history of myocardial infarction.
https://acpinternist.org/weekly/archives/2022/11/01/4.htm
1 Nov 2022

Managing DOACs in primary care

Primary care physicians play a crucial role in ongoing anticoagulation management, including educating patients about the signs of venous thromboembolism.
https://acpinternist.org/archives/2022/04/managing-doacs-in-primary-care.htm
1 Apr 2022

Latest COVID-19 research on VTE risk, treatment with metformin, ivermectin, fluvoxamine

Unvaccinated patients may have higher risk of venous thromboembolism (VTE) when mildly ill, one study found, while another showed no effect from metformin, ivermectin, or fluvoxamine. Research supported the safety of the mRNA vaccines, and the NIH updated its treatment guidelines.
https://acpinternist.org/weekly/archives/2022/08/23/4.htm
23 Aug 2022

New resource offers pearls for perioperative medicine

A recent book addresses perioperative medicine, including how to be a perioperative consultant, prophylaxis for venous thromboembolism, coexisting medical problems, and common postoperative complications.
https://acpinternist.org/archives/2022/02/new-resource-offers-pearls-for-perioperative-medicine.htm
1 Feb 2022

Higher risk for DVT, PE, bleeding seen after COVID-19; long-term risk for VTE recurrence may be low

A Swedish study found that patients who had COVID-19 were at higher risk for a first deep venous thrombosis (DVT) for up to three months, pulmonary embolism (PE) for up to six months, and bleeding for up to two months, while a single-center study from France found that risk for venous thromboembolism (VTE) recurrence up to a year after COVID-19 was low.
https://acpinternist.org/weekly/archives/2022/04/12/2.htm
12 Apr 2022

Apixaban shows superior effectiveness, safety compared to rivaroxaban

For patients with venous thromboembolism, initiation of apixaban was associated with lower rates of recurrence and intracranial and gastrointestinal bleeding than rivaroxaban in a population-based cohort study.
https://acpinternist.org/weekly/archives/2021/12/07/2.htm
7 Dec 2021

Pros, cons of prolonged anticoagulation after a clot

Experts debate about provoked vs. unprovoked venous thromboembolism, and whether a once-high-risk patient can have that status removed later.
https://acpinternist.org/archives/2020/02/pros-cons-of-prolonged-anticoagulation-after-a-clot.htm
1 Feb 2020

DOACs may be safe, effective for VTE prevention in patients with higher weight, BMI

Patients with first-time venous thromboembolism (VTE) who weighed 120 kg or more and had a body mass index (BMI) of 40 kg/m2 or more were not at higher risk for bleeding or recurrent VTE with direct-acting oral anticoagulants (DOACs) versus warfarin.
https://acpinternist.org/weekly/archives/2021/11/09/4.htm
9 Nov 2021

Gestational diabetes associated with risks later in life, but lifestyle makes a difference, studies find

A review found increased risks of cardiovascular and cerebrovascular disease in women who had gestational diabetes, while another study showed that five markers of a healthy lifestyle were associated with a significant reduction in risk of developing type 2 diabetes after gestational diabetes.
https://acpinternist.org/weekly/archives/2022/09/27/4.htm
27 Sep 2022

MKSAP Quiz: ED evaluation for midsternal pain

A 59-year-old woman is evaluated in the emergency department for midsternal chest pain. The pain began several hours ago as a vague ache in her left upper sternal region that progressed in intensity and severity. The pain abated spontaneously after approximately 45 minutes. She had no further chest pain until several hours later, when it recurred unprovoked by exertion. She has no shortness of breath, nausea or vomiting, syncope, previous history of chest pain, or known cardiac disease or risk factors for venous thromboembolism. Medical history is significant for hyperlipidemia and hypertension. She does not smoke cigarettes. Medications are simvastatin, aspirin, lisinopril, and hydrochlorothiazide. Following a physical exam, electrocardiogram and chest radiograph, what is the most appropriate initial management?.
https://acpinternist.org/archives/2014/04/mksap.htm
1 Apr 2014

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next